UPDATE: Abbott (ABT) Tops Q3 EPS by 1c, Updates FY Guidance
Abbott (NYSE: ABT) reported Q3 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $6.83 billion versus the consensus estimate of $6.72 billion.
GUIDANCE:
Abbott narrowed its full-year 2017 EPS guidance range, which continues to reflect double-digit growth.
Abbott sees FY2017 EPS of $2.48-$2.50, versus the consensus of $2.50.
"We''re very pleased with our performance and the steady cadence of innovative new product launches that are contributing to growth," said Miles D. White, chairman and chief executive officer, Abbott. "We're well-positioned to achieve the upper end of our initial full-year EPS guidance range."
For earnings history and earnings-related data on Abbott (ABT) click here.